May 2008
Volume 49, Issue 13
ARVO Annual Meeting Abstract  |   May 2008
Does Sebaceous Cell Carcinoma Have a Unique Immunophenotype?
Author Affiliations & Notes
  • S. E. Gorovoy
    F.C. Blodi Eye Pathology Laboratory, University of Iowa Department of Ophthalmology & Visual Sciences, Iowa City, Iowa
  • N. A. Syed
    F.C. Blodi Eye Pathology Laboratory, University of Iowa Department of Ophthalmology & Visual Sciences, Iowa City, Iowa
  • Footnotes
    Commercial Relationships  S.E. Gorovoy, None; N.A. Syed, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 5697. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. E. Gorovoy, N. A. Syed; Does Sebaceous Cell Carcinoma Have a Unique Immunophenotype?. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5697. doi:

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Sebaceous cell carcinoma has a high clinical and pathological misdiagnosis rate. The purpose of our study is to investigate the immunophenotypes of sebaceous cell carcinoma, basal cell carcinoma (BCCA) and squamous cell carcinoma (SCCA) of the eyelid using commercially available antibodies in an effort to determine whether sebaceous cell carcinoma has a unique phenotype that may help to distinguish it from other eyelid malignancies.

Methods: : Formalin fixed, paraffin embedded specimens from 22 sebaceous, 22 basal cell, and 16 squamous cell carcinomas were identified from the archives of the F.C. Blodi Eye Pathology Laboratory at the University of Iowa between 1997 and 2007. Cases were reviewed for diagnostic accuracy. Using a standard immunoperoxidase technique, the following antibodies were applied: Ber Ep4, BRST 2 (GCDFP15), CAM 5.2, CEA, CK7, CK20, EMA, Her 2, HMFG 1 and HMFG 2. Interpretation of staining results was performed by 2 independent graders in a masked fashion.

Results: : Cases of sebaceous cell carcinoma were much more likely to express EMA and Her 2 when compared with cases of BCCA and SCCA. Both sebaceous cell carcinomas and BCCAs demonstrated expression of Ber Ep4. Results of immunohistochemistry with the other antibodies listed above were not significantly different between the three tumor types.

Conclusions: : Sebaceous cell carcinoma does appear to have a significantly unique immunophenotype when compared with other common malignant eyelid neoplasms. The antigens EMA, Ber Ep4, and Her 2 are expressed by the majority of sebaceous cell carcinomas, suggesting that a panel of immunohistochemical stains can be useful in distinguishing this tumor from BCCA and SCCA.

Keywords: pathology: human • tumors • eyelid 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.